Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;112:3239-3246
doi: 10.1161/CIRCULATIONAHA.105.564008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, K.
Right arrow Articles by Roden, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, K.
Right arrow Articles by Roden, D. M.
Related Collections
Right arrow Arrythmias-basic studies

(Circulation. 2005;112:3239-3246.)
© 2005 American Heart Association, Inc.


Arrhythmia/Electrophysiology

New Mechanism Contributing to Drug-Induced Arrhythmia

Rescue of a Misprocessed LQT3 Mutant

Kai Liu, MD; Tao Yang, PhD; Prakash C. Viswanathan, PhD; Dan M. Roden, MD

From the Departments of Medicine, Pharmacology, and Anesthesiology, Vanderbilt University School of Medicine, Nashville, Tenn.

Correspondence to Dan M. Roden, MD, Professor of Medicine and Pharmacology Director, Oates Institute for Experimental Therapeutics, Vanderbilt University School of Medicine, 1285B Medical Research Building IV, Nashville, TN 37232. E-mail dan.roden{at}vanderbilt.edu

Received May 22, 2005; revision received August 18, 2005; accepted September 1, 2005.

Background— The cardiac sodium channel (SCN5A) mutation L1825P has been identified in a patient with drug-induced torsade de pointes precipitated by the IKr blocker cisapride. Although L1825P generates late sodium current typical of SCN5A-linked long-QT syndrome (LQT3) in vitro, the patient reported had a normal QT interval before administration of the drug. To address this discrepancy, we tested the hypothesis that this mutant channel is not processed normally.

Methods and Results— CHO cells transfected with L1825P displayed significantly reduced peak INa (209±36 versus 23±3 pA/pF, P<0.05). Confocal imaging and cell-counting studies using epitope-tagged constructs demonstrated that cell surface expression of the mutant was only {approx}9% of wild-type. Incubating transfected cells with cisapride partially rescued misprocessing to 30% of wild-type. As a result, "late" sodium current increased with cisapride from 1.2±0.11 to 5.04±0.77 pA/pF (P<0.05).

Conclusions— L1825P fails to generate QT prolongation because it does not reach the cell surface. Moreover, the data suggest that cisapride caused torsade de pointes not only by blocking IKr but also by rescuing cell surface expression of the mutant channel, further exaggerating the LQT3 phenotype. This not only represents a new mechanism in the drug-induced long-QT syndrome but also strongly supports the concept that variable cell surface expression contributes to clinical variability in the LQT3 phenotype.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
CirculationHome page
D. Darbar, P. J. Kannankeril, B. S. Donahue, G. Kucera, T. Stubblefield, J. L. Haines, A. L. George Jr, and D. M. Roden
Cardiac Sodium Channel (SCN5A) Variants Associated with Atrial Fibrillation
Circulation, April 15, 2008; 117(15): 1927 - 1935.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. P. Nguyen, D. W. Wang, T. H. Rhodes, and A. L. George Jr
Divergent Biophysical Defects Caused by Mutant Sodium Channels in Dilated Cardiomyopathy With Arrhythmia
Circ. Res., February 15, 2008; 102(3): 364 - 371.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
J. S. Lowe, O. Palygin, N. Bhasin, T. J. Hund, P. A. Boyden, E. Shibata, M. E. Anderson, and P. J. Mohler
Voltage-gated Nav channel targeting in the heart requires an ankyrin-G dependent cellular pathway
J. Cell Biol., January 10, 2008; 180(1): 173 - 186.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B.-H. Tan, P. Iturralde-Torres, A. Medeiros-Domingo, S. Nava, D. J. Tester, C. R. Valdivia, T. Tusie-Luna, M. J. Ackerman, and J. C. Makielski
A novel C-terminal truncation SCN5A mutation from a patient with sick sinus syndrome, conduction disorder and ventricular tachycardia
Cardiovasc Res, December 1, 2007; 76(3): 409 - 417.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. E. Lehnart, M. J. Ackerman, D. W. Benson Jr, R. Brugada, C. E. Clancy, J. K. Donahue, A. L. George Jr, A. O. Grant, S. C. Groft, C. T. January, et al.
Inherited Arrhythmias: A National Heart, Lung, and Blood Institute and Office of Rare Diseases Workshop Consensus Report About the Diagnosis, Phenotyping, Molecular Mechanisms, and Therapeutic Approaches for Primary Cardiomyopathies of Gene Mutations Affecting Ion Channel Function
Circulation, November 13, 2007; 116(20): 2325 - 2345.
[Abstract] [Full Text] [PDF]